相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Next-generation active immunization approach for synucleinopathies: implications for Parkinson's disease clinical trials
Markus Mandler et al.
ACTA NEUROPATHOLOGICA (2014)
Cytokine Gene Polymorphisms and Parkinson's Disease: A Meta-Analysis
Chu Ketan et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2014)
Lipid Peroxidation Product 4-Hydroxy-2-Nonenal Promotes Seeding-Capable Oligomer Formation and Cell-to-Cell Transfer of α-Synuclein
Eun-Jin Bae et al.
ANTIOXIDANTS & REDOX SIGNALING (2013)
Neuroimmunological processes in Parkinson's disease and their relation to alpha-synuclein: microglia as the referee between neuronal processes and peripheral immunity
Vanesa Sanchez-Guajardo et al.
ASN NEURO (2013)
Dopamine Receptor D3 Expressed on CD4+ T Cells Favors Neurodegeneration of Dopaminergic Neurons during Parkinson's Disease
Hugo Gonzalez et al.
JOURNAL OF IMMUNOLOGY (2013)
Adrenergic and Dopaminergic Modulation of Immunity in Multiple Sclerosis: Teaching Old Drugs New Tricks?
Marco Cosentino et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)
The Different Clinical Effects of Anti-BLyS, Anti-APRIL and Anti-CD20 Antibodies Point at a Critical Pathogenic Role of γ-Herpesvirus Infected B Cells in the Marmoset EAE Model
S. Anwar Jagessar et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)
GM-CSF induces neuroprotective and anti-inflammatory responses in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxicated mice
Lisa M. Kosloski et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
α-Synuclein Vaccination Prevents the Accumulation of Parkinson Disease-Like Pathologic Inclusions in Striatum in Association With Regulatory T Cell Recruitment in a Rat Model
Vanesa Sanchez-Guajardo et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2013)
Bacillus Calmette-Guerin vaccine-mediated neuroprotection is associated with regulatory T-cell induction in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease
Goran Lacan et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2013)
Naturally occurring α-synuclein autoantibody levels are lower in patients with Parkinson disease
Daniela Besong-Agbo et al.
NEUROLOGY (2013)
Natural IgG Autoantibodies Are Abundant and Ubiquitous in Human Sera, and Their Number Is Influenced By Age, Gender, and Disease
Eric P. Nagele et al.
PLOS ONE (2013)
Immunotherapy for neurodegenerative diseases: Focus on α-synucleinopathies
Elvira Valera et al.
PHARMACOLOGY & THERAPEUTICS (2013)
The primate EAE model points at EBV-infected B cells as a preferential therapy target in multiple sclerosis
Bert A. T'Hart et al.
FRONTIERS IN IMMUNOLOGY (2013)
Neuro-protective effects of bee venom by suppression of neuroinflammatory responses in a mouse model of Parkinson's disease: Role of regulatory T cells
Eun Sook Chung et al.
BRAIN BEHAVIOR AND IMMUNITY (2012)
Immunology, Autoimmunity, and Autoantibodies in Parkinson's Disease
Michal Benkler et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2012)
Inflammatory cytokines and NT-proCNP in Parkinson's disease patients
Dariusz Koziorowski et al.
CYTOKINE (2012)
Effects of peripheral lymphocyte subpopulations and the clinical correlation with Parkinson's disease
Fumitoshi Niwa et al.
GERIATRICS & GERONTOLOGY INTERNATIONAL (2012)
Dopaminergic therapies modulate the T-CELL proteome of patients with Parkinson's disease
Tiziana Alberio et al.
IUBMB LIFE (2012)
B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells
Tom A. Barr et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice
Kelvin C. Luk et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Stimulation of Dopamine Receptor D5 Expressed on Dendritic Cells Potentiates Th17-Mediated Immunity
Carolina Prado et al.
JOURNAL OF IMMUNOLOGY (2012)
CD4+Regulatory and Effector/Memory T Cell Subsets Profile Motor Dysfunction in Parkinson's Disease
Jessica A. Hutter Saunders et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2012)
Reduced T helper and B lymphocytes in Parkinson's disease
Claire H. Stevens et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
Impact of intravenous immunoglobulin on the dopaminergic system and immune response in the acute MPTP mouse model of Parkinson's disease
Isabelle St-Amour et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Antibody-Aided Clearance of Extracellular α-Synuclein Prevents Cell-to-Cell Aggregate Transmission
Eun-Jin Bae et al.
JOURNAL OF NEUROSCIENCE (2012)
Dopaminergic Modulation of CD4+CD25high Regulatory T Lymphocytes in Multiple Sclerosis Patients during Interferon-β Therapy
Marco Cosentino et al.
NEUROIMMUNOMODULATION (2012)
Non-Motor Symptoms in Patients with Parkinson's Disease - Correlations with Inflammatory Cytokines in Serum
Daniel Lindqvist et al.
PLOS ONE (2012)
Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
Kelvin C. Luk et al.
SCIENCE (2012)
Increased α-synuclein phosphorylation and nitration in the aging primate substantia nigra
A. L. McCormack et al.
CELL DEATH & DISEASE (2012)
Inflammation and Adaptive Immunity in Parkinson's Disease
R. Lee Mosley et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
The anatomical and cellular basis of immune surveillance in the central nervous system
Richard M. Ransohoff et al.
NATURE REVIEWS IMMUNOLOGY (2012)
The role of antibodies in multiple sclerosis
Martin S. Weber et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Parkinson's disease is associated with increased serum levels of macrophage migration inhibitory factor
Alessandra Nicoletti et al.
CYTOKINE (2011)
The duality of TNF signaling outcomes in the brain: Potential mechanisms?
Christopher J. Barnum et al.
EXPERIMENTAL NEUROLOGY (2011)
Pathways towards an effective immunotherapy for Parkinson's disease
Jessica A. L. Hutter-Saunders et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2011)
Therapy with anti-TNF alpha Antibody Enhances Number and Function of Foxp(3+) Regulatory T Cells in Inflammatory Bowel Diseases
Gilles Boschetti et al.
INFLAMMATORY BOWEL DISEASES (2011)
GM-CSF-induced, bone-marrow-derived dendritic cells can expand natural Tregs and induce adaptive Tregs by different mechanisms
Palash Bhattacharya et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2011)
Dopamine up-regulates Th17 phenotype from individuals with generalized anxiety disorder
Thais B. Ferreira et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
Immunoprotection against toxic biomarkers is retained during Parkinson's disease progression
Marina A. Gruden et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
A case for regulatory B cells in controlling the severity of autoimmune-mediated inflammation in experimental autoimmune encephalomyelitis and multiple sclerosis
Avijit Ray et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
Augmentation of regulatory B cell activity in experimental allergic encephalomyelitis by glatiramer acetate
Sakhina Begum-Haque et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
B cells in spontaneous autoimmune diseases of the central nervous system
Kerstin Berer et al.
MOLECULAR IMMUNOLOGY (2011)
Delayed Dominant-Negative TNF Gene Therapy Halts Progressive Loss of Nigral Dopaminergic Neurons in a Rat Model of Parkinson's Disease
Ashley S. Harms et al.
MOLECULAR THERAPY (2011)
Peripheral expression of key regulatory kinases in Alzheimer's disease and Parkinson's disease
M. T. Armentero et al.
NEUROBIOLOGY OF AGING (2011)
Serum Levels of Chemokines in Parkinson's Disease
Paula Scalzo et al.
NEUROIMMUNOMODULATION (2011)
Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death
Laura A. Volpicelli-Daley et al.
NEURON (2011)
Vaccination for Parkinson's disease
A. Schneeberger et al.
PARKINSONISM & RELATED DISORDERS (2011)
BCG Vaccine-Induced Neuroprotection in a Mouse Model of Parkinson's Disease
Jing Yong et al.
PLOS ONE (2011)
α-Synuclein Reactive Antibodies as Diagnostic Biomarkers in Blood Sera of Parkinson's Disease Patients
Kiran Yanamandra et al.
PLOS ONE (2011)
Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease
Eliezer Masliah et al.
PLOS ONE (2011)
Diagnosis of Alzheimer's Disease Based on Disease-Specific Autoantibody Profiles in Human Sera
Eric Nagele et al.
PLOS ONE (2011)
A novel molecular mechanism for nitrated α-synuclein-induced cell death
Yanying Liu et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2011)
Short communication Interleukin-6 levels in cerebrospinal fluid inversely correlate to severity of Parkinson's disease
T. Müller et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
Parkinson's disease and immunological abnormalities: increase of HLA-DR expression on monocytes in cerebrospinal fluid and of CD45RO+ T cells in peripheral blood
U. Fiszer et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
An Association between Immunosenescence and CD4+CD25+ Regulatory T Cells: A Systematic Review
Ling Wang et al.
BIOMEDICAL AND ENVIRONMENTAL SCIENCES (2010)
The immunoregulatory role of dopamine: An update
Chandrani Sarkar et al.
BRAIN BEHAVIOR AND IMMUNITY (2010)
Brain-reactive autoantibodies are nearly ubiquitous in human sera and may be linked to pathology in the context of blood-brain barrier breakdown
Eli C. Levin et al.
BRAIN RESEARCH (2010)
Th17 and Regulatory T Cells in Mediating and Restraining Inflammation
Dan R. Littman et al.
CELL (2010)
Regulation of immunity and autoimmunity by B cells
Claudia Mauri
CURRENT OPINION IN IMMUNOLOGY (2010)
Regulatory T Cells Attenuate Th17 Cell-Mediated Nigrostriatal Dopaminergic Neurodegeneration in a Model of Parkinson's Disease
Ashley D. Reynolds et al.
JOURNAL OF IMMUNOLOGY (2010)
Apoptosis of peripheral blood lymphocytes in Parkinson patients
Matil Calopa et al.
NEUROBIOLOGY OF DISEASE (2010)
Serum levels of interleukin-6 are elevated in patients with Parkinson's disease and correlate with physical performance
Paula Scalzo et al.
NEUROSCIENCE LETTERS (2010)
Microglia Acquire Distinct Activation Profiles Depending on the Degree of α-Synuclein Neuropathology in a rAAV Based Model of Parkinson's Disease
Vanesa Sanchez-Guajardo et al.
PLOS ONE (2010)
Nitrated α-Synuclein Induces the Loss of Dopaminergic Neurons in the Substantia Nigra of Rats
Zhongwang Yu et al.
PLOS ONE (2010)
T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening?
Stanley H. Appel et al.
TRENDS IN IMMUNOLOGY (2010)
Circulating interleukin-10 and interleukin-12 in Parkinson's disease
M. Rentzos et al.
ACTA NEUROLOGICA SCANDINAVICA (2009)
Innate and Adaptive Immunity for the Pathobiology of Parkinson's Disease
David K. Stone et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
Peripheral cytokines profile in Parkinson's disease
M. Reale et al.
BRAIN BEHAVIOR AND IMMUNITY (2009)
Transcriptional regulatory networks in Th17 cell differentiation
Liang Zhou et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
The TNF superfamily in 2009: new pathways, new indications, and new drugs
Malu G. Tansey et al.
DRUG DISCOVERY TODAY (2009)
Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model
Na K. Kim et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2009)
Anti-melanin antibodies are increased in sera in Parkinson's disease
K. L. Double et al.
EXPERIMENTAL NEUROLOGY (2009)
Roles of B lymphocytes in multiple sclerosis: diversifying beyond the antibody response
P. Fontoura
IMMUNOTHERAPY (2009)
Dopamine released by dendritic cells polarizes Th2 differentiation
Kazuhisa Nakano et al.
INTERNATIONAL IMMUNOLOGY (2009)
Nitrated α-Synuclein-Induced Alterations in Microglial Immunity Are Regulated by CD4+ T Cell Subsets
Ashley D. Reynolds et al.
JOURNAL OF IMMUNOLOGY (2009)
Role of dopamine in the physiology of T-cells and dendritic cells
Rodrigo Pacheco et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
Increased serum levels of soluble tumor necrosis factor-α receptor-1 in patients with Parkinson's disease
Paula Scalzo et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
When Does Parkinson's Disease Begin?
Carles Gaig et al.
MOVEMENT DISORDERS (2009)
Interleukin-6 Serum Levels in Patients with Parkinson's Disease
Kerly Wollmeister Hofmann et al.
NEUROCHEMICAL RESEARCH (2009)
CXCR4 and CXCL12 Expression is Increased in the Nigro-Striatal System of Parkinson's Disease
Mika Shimoji et al.
NEUROTOXICITY RESEARCH (2009)
Increased oxidative stress in lymphocytes from untreated Parkinson's disease patients
Alessandro Prigione et al.
PARKINSONISM & RELATED DISORDERS (2009)
Neurotransmitters activate T-cells and elicit crucial functions via neurotransmitter receptors
Mia Levite
CURRENT OPINION IN PHARMACOLOGY (2008)
HsP104 antagonizes α-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease
Christophe Lo Bianco et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
TLR-activated B cells suppress T cell-mediated autoimmunity
Vicky Lampropoulou et al.
JOURNAL OF IMMUNOLOGY (2008)
TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease
Melissa K. Mccoy et al.
JOURNAL OF NEUROINFLAMMATION (2008)
Targeted Overexpression of Human α-Synuclein Triggers Microglial Activation and an Adaptive Immune Response in a Mouse Model of Parkinson Disease
Shaji Theodore et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
Neuroinflammation and oxidation/nitration of α-synuclein linked to dopaminergic neurodegeneration
Hui-Ming Gao et al.
JOURNAL OF NEUROSCIENCE (2008)
Oxidative-stress-induced apoptosis in PBLs of two patients with Parkinson disease secondary to alpha-synuclein mutation
Carla Battisti et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
B cells and multiple sclerosis
Diego Franciotta et al.
LANCET NEUROLOGY (2008)
Intranigral lentiviral delivery of dominant-negative TNF attenuates neurodegeneration and behavioral deficits in hemiparkinsonian rats
Melissa K. McCoy et al.
MOLECULAR THERAPY (2008)
Antineuronal antibodies in Parkinson's disease
Bart P. C. van de Warrenburg et al.
MOVEMENT DISORDERS (2008)
Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNFα, and INFγ concentrations are elevated in patients with atypical and idiopathic parkinsonism
Bogdan Brodacki et al.
NEUROSCIENCE LETTERS (2008)
Nitrated α-Synuclein Immunity Accelerates Degeneration of Nigral Dopaminergic Neurons
Eric J. Benner et al.
PLOS ONE (2008)
Ubiquitination of α-synuclein by Siah-1 promotes α-synuclein aggregation and apoptotic cell death
James T. Lee et al.
HUMAN MOLECULAR GENETICS (2008)
Nitrated alpha-synuclein-activated microglial profiling for Parkinson's disease
Ashley D. Reynolds et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Circulating interleukin-15 and RANTES chemokine in Parkinson's disease
M. Rentzos et al.
ACTA NEUROLOGICA SCANDINAVICA (2007)
Neuroinflammatory mechanisms in Parkinson's disease: Potential environmental triggers, pathways, and targets for early therapeutic intervention
Malu G. Tansey et al.
EXPERIMENTAL NEUROLOGY (2007)
Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson's disease
Ashley D. Reynolds et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Higher frequency of regulatory T suppressive activity cells in the elderly and increased in neurodegeneration
Daniela Rosenkranz et al.
JOURNAL OF NEUROIMMUNOLOGY (2007)
Autoantibodies to alpha-synuclein in inherited Parkinson's disease
Katerina K. Papachroni et al.
JOURNAL OF NEUROCHEMISTRY (2007)
The role of STAT3 in antigen-IgG inducing regulatory CD4+Foxp3+T cells
Renxi Wang et al.
CELLULAR IMMUNOLOGY (2007)
B cell regulation of CD4+CD25+ T regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis
Monica K. Mann et al.
JOURNAL OF IMMUNOLOGY (2007)
IL-2 is essential for TGF-β to convert naive CD4+CD25- cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells
Song Guo Zheng et al.
JOURNAL OF IMMUNOLOGY (2007)
CD4+ T cells from Copolymer-1 immunized mice protect dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease
Chad Laurie et al.
JOURNAL OF NEUROIMMUNOLOGY (2007)
Human CD4+CD25+ regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine/paracrine inhibitory functional loop
Marco Cosentino et al.
BLOOD (2007)
Cutting edge:: Stimulation of dopamine D4 receptors induce T cell quiescence by up-regulating Kruppel-like factor-2 expression through inhibition of ERK1/ERK2 phosphorylation
Chandrani Sarkar et al.
JOURNAL OF IMMUNOLOGY (2006)
Peripheral inflammation and neuroprotection: Systemic pretreatment with complete Freund's adjuvant reduces 6-hydroxydopamine toxicity in a rodent model of Parkinson's disease
Marie-Therese Armentero et al.
NEUROBIOLOGY OF DISEASE (2006)
Dopamine targets cycling B cells independent of receptors/transporter for oxidative attack:: Implications for non-Hodgkin's lymphoma
Elizabeth J. Meredith et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Oxidative stress in peripheral blood mononuclear cells from patients with Parkinson's disease: Negative correlation with levodopa dosage
Alessandro Prigione et al.
NEUROBIOLOGY OF DISEASE (2006)
Indexation as a novel mechanism of lymphocyte homeostasis:: The number of CD4+CD25+ regulatory T cells is indexed to the number of IL-2-producing cells
Afonso R. M. Almeida et al.
JOURNAL OF IMMUNOLOGY (2006)
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
E Bettelli et al.
NATURE (2006)
Dopamine by itself activates either D2, D3 or D1/D5 dopaminergic receptors in normal human T-cells and triggers the selective secretion of either IL-10, TNFα or both
MJ Besser et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Inducing and expanding regulatory T cell populations by foreign antigen
K Kretschmer et al.
NATURE IMMUNOLOGY (2005)
A possible role for humoral immunity in the pathogenesis of Parkinson's disease
CF Orr et al.
BRAIN (2005)
Dopamine fails to regulate activation of peripheral blood lymphocytes from multiple sclerosis patients:: Effects of IFN-β
M Giorelli et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2005)
A precipitating role for truncated α-synuclein and the proteasome in α-synuclein aggregation -: Implications for pathogenesis of Parkinson disease
CW Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Effects of α-synuclein immunization in a mouse model of Parkinson's disease
E Masliah et al.
NEURON (2005)
Effects of nitration on the structure and aggregation of α-synuclein
VN Uversky et al.
MOLECULAR BRAIN RESEARCH (2005)
Alterations of T-lymphocyte populations in Parkinson disease
Y Baba et al.
PARKINSONISM & RELATED DISORDERS (2005)
Immunization with myelin oligodendrocyte glygoprotein and complete freund neurons from 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced damage in mouse model of Parkinson's disease
I Kurkowska-Jastrzebska et al.
NEUROSCIENCE (2005)
The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia
JJ Zarranz et al.
ANNALS OF NEUROLOGY (2004)
Comparison of kindreds with parkinsonism and α-synuclein genomic multiplications
M Farrer et al.
ANNALS OF NEUROLOGY (2004)
Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFα therapy
MR Ehrenstein et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Dopamine, through the extracellular signal-regulated kinase pathway, downregulates CD4+CD25+ regulatory T-cell activity:: Implications for neurodegeneration
J Kipnis et al.
JOURNAL OF NEUROSCIENCE (2004)
Vaccination with autoantigen protects against aggregated β-amyloid and glutamate toxicity by controlling microglia:: effect of CD4+CD25+ T cells
H Avidan et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Functional consequences of α-synuclein tyrosine nitration -: Diminished binding to lipid vesicles and increased fibril formation
R Hodara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease
EJ Benner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Dopaminergic modulation of oxidative stress and apoptosis in human peripheral blood lymphocytes: Evidence for a D1-like receptor-dependent protective effect
M Cosentino et al.
FREE RADICAL BIOLOGY AND MEDICINE (2004)
α-synuclein locus triplication causes Parkinson's disease
AB Singleton et al.
SCIENCE (2003)
The enhancement of T cell proliferation by L-dopa is mediated peripherally and does not involve interleukin-2
L Carr et al.
JOURNAL OF NEUROIMMUNOLOGY (2003)
Lymphocytes transport serotonin and dopamine: agony or ecstasy?
J Gordon et al.
TRENDS IN IMMUNOLOGY (2003)
Dopamine inhibits cytokine release and expression of tyrosine kinases, Lck and Fyn in activated T cells
MC Ghosh et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2003)
Nitration inhibits fibrillation of human α-synuclein in vitro by formation of soluble oligomers
G Yamin et al.
FEBS LETTERS (2003)
In vivo administration of L-dopa or dopamine decreases the number of splenic IFN-γ-producing cells
L Carr et al.
JOURNAL OF NEUROIMMUNOLOGY (2003)
Staging of brain pathology related to sporadic Parkinson's disease
H Braak et al.
NEUROBIOLOGY OF AGING (2003)
Parkinson's syndrome associated with neurofibrillary degeneration and tau pathologic findings
AJ Lees
MOVEMENT DISORDERS (2003)
Expression of the dopamine transporter gene is regulated by the 3′ UTR VNTR:: Evidence from brain and lymphocytes using quantitative RT-PCR
J Mill et al.
AMERICAN JOURNAL OF MEDICAL GENETICS (2002)
Catecholamine production and tyrosine hydroxylase expression in peripheral blood mononuclear cells from multiple sclerosis patients: effect of cell stimulation and possible relevance for activation-induced apoptosis
M Cosentino et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Homeostasis of peripheral CD4+ T cells:: IL-2Rα and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers
ARM Almeida et al.
JOURNAL OF IMMUNOLOGY (2002)
B cells regulate autoimmunity by provision of IL-10
S Fillatreau et al.
NATURE IMMUNOLOGY (2002)
Role of Fcγ receptors in nigral cell injury induced by Parkinson disease immunoglobulin injection into mouse substantia nigra
Y He et al.
EXPERIMENTAL NEUROLOGY (2002)
Impaired production of plasma interleukin-6 in patients with Parkinson's disease
MV Selikhova et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2002)
Increase in peripheral CD4 bright+ CD8 dull+ T cells in Parkinson disease
K Hisanaga et al.
ARCHIVES OF NEUROLOGY (2001)
Identification of dopamine plasma membrane and vesicular transporters in human peripheral blood lymphocytes
F Amenta et al.
JOURNAL OF NEUROIMMUNOLOGY (2001)
Circulating dopamine level, in lung carcinoma patients, inhibits proliferation and cytotoxicity of CD4+and CD8+T cells by D1 dopamine receptors: an in vitro analysis
B Saha et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2001)
Lymphocyte populations in Parkinson's disease and in rat models of parkinsonism
J Bas et al.
JOURNAL OF NEUROIMMUNOLOGY (2001)
Physiological concentrations of dopamine inhibit the proliferation and cytotoxicity of human CD4+and CD8+T cells in vitro: A receptor-mediated mechanism
B Saha et al.
NEUROIMMUNOMODULATION (2001)
Impaired cytokine production by peripheral blood mononuclear cells and monocytes/macrophages in Parkinson's disease
Y Hasegawa et al.
ACTA NEUROLOGICA SCANDINAVICA (2000)
分享论文
